RESEARCH PAPER / 2025-11-06
Intranasal Insulin Mitigates Memory Impairment and Neuroinflammation in a Mouse Model of Hippocampal Aging.
Abstract
Aging is a complex process that frequently includes cognitive decline with memory loss. In the hippocampus, the number of somatostatin-positive (Sst
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
Intranasal insulin administration can reduce memory impairment and neuroinflammation in aging mice. This study addresses cognitive decline associated with aging, suggesting a potential intervention that targets mechanisms underlying age-related memory loss.
Author of this paper? Send a correction.